Literature DB >> 9754545

Effects of low (modified-live virus vaccine) and high (VR-2385)-virulence strains of porcine reproductive and respiratory syndrome virus on pulmonary clearance of copper particles in pigs.

R Thanawongnuwech1, P G Halbur, M R Ackermann, E L Thacker, R L Royer.   

Abstract

Seventy-five 3-week-old, crossbred pigs from a herd free of porcine reproductive and respiratory syndrome virus (PRSSV) were randomly assigned to three groups: uninfected controls, pigs inoculated intranasally with RespPRRS/Repro modified-live virus vaccine (RespPRRS), and pigs inoculated intranasally with a high-virulence strain of PRRSV (VR-2385). Pigs were intravenously infused with 3% copper phthalocyanine tetrasulfonic acid (0.2 ml/kg) in normal saline 30 minutes before necropsy, which was performed 3, 7, 10, 14, or 28 days postinoculation (DPI) with PRRSV. There were no differences in serum copper concentration in samples collected at 0, 15, or 30 minutes after infusion. Copper concentrations in the lungs of VR-2385-inoculated pigs were significantly lower than levels in the lungs of control and RespPRRS-inoculated pigs at 7, 10, and 14 DPI (P < 0.05). The greatest difference between the groups was observed at 10 DPI. Liver and spleen copper concentrations were slightly, but not significantly, higher in both PRRSV-infected groups. The percentage of lung affected by grossly visible pneumonia ranged from 0 to 5.6% in the RespPRRS-inoculated group and from 15.2 to 46.4% in the VR-2385-inoculated group, with lesions peaking at 7 and 10 DPI, respectively. PRRSV antigen was demonstrated in both pulmonary alveolar macrophages (PAMs) and pulmonary intravascular macrophages (PIMs) by immunohistochemical methods. Copper particles were demonstrated in the PIMs by light microscopy. PRRSV was isolated from bronchoalveolar lavage fluid of VR-2385-infected pigs from 3 to 28 DPI and from RespPRRS-inoculated pigs from 7 to 28 DPI. No PRRSV, PRRSV antibodies, or PRRSV-induced pneumonia was detected in the control group. These results suggest that 1) PRRSV has a detrimental effect on the uptake of copper particles by PIMs, 2) the severity of PRRSV-induced damage to PIMs differs among strains, and 3) demonstration of PRRSV-induced decreased pulmonary clearance supports the hypothesis that PRRSV infection may make pigs more susceptible to bacterial septicemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754545     DOI: 10.1177/030098589803500509

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  11 in total

1.  Ultrastructural response of pulmonary intravascular macrophages to exogenous oestrogen in the bovine lung: translocation of the surface-coat and enhanced cell membrane plasticity and angiogenesis.

Authors:  O S Atwal; K J Minhas; C S Williams
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

2.  Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2.

Authors:  A Rovira; M Balasch; J Segalés; L García; J Plana-Durán; C Rosell; H Ellerbrok; A Mankertz; M Domingo
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs.

Authors:  P Halbur; R Thanawongnuwech; G Brown; J Kinyon; J Roth; E Thacker; B Thacker
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

4.  Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate.

Authors:  Uladzimir U Karniychuk; Marc Geldhof; Merijn Vanhee; Jan Van Doorsselaere; Tamara A Saveleva; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2010-06-04       Impact factor: 2.741

5.  Different biological characteristics of wild-type porcine reproductive and respiratory syndrome viruses and vaccine viruses and identification of the corresponding genetic determinants.

Authors:  Won-Il Kim; Jae-Jo Kim; Sang-Ho Cha; Kyoung-Jin Yoon
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

6.  Efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS) against a Thai HP-PRRSV challenge.

Authors:  Chaitawat Sirisereewan; Yonlayong Woonwong; Jirapat Arunorat; Roongtham Kedkovid; Teerawut Nedumpun; Sawang Kesdangsakonwut; Sanipa Suradhat; Roongroje Thanawongnuwech; Komkrich Teankum
Journal:  Trop Anim Health Prod       Date:  2018-04-26       Impact factor: 1.559

7.  Impairment of the antibody-dependent phagocytic function of PMNs through regulation of the FcγRs expression after porcine reproductive and respiratory syndrome virus infection.

Authors:  Bo Wan; Songlin Qiao; Peng Li; Qianyue Jin; Yunchao Liu; Dengke Bao; Mingyang Liu; Yinbiao Wang; Gaiping Zhang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Porcine Alveolar Macrophage-like cells are pro-inflammatory Pulmonary Intravascular Macrophages that produce large titers of Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Elise Bordet; Pauline Maisonnasse; Patricia Renson; Edwige Bouguyon; Elisa Crisci; Mathieu Tiret; Delphyne Descamps; Cindy Bernelin-Cottet; Céline Urien; François Lefèvre; Luc Jouneau; Olivier Bourry; Jean-Jacques Leplat; Isabelle Schwartz-Cornil; Nicolas Bertho
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

9.  Comparative analysis of complete nucleotide sequence of porcine reproductive and respiratory syndrome virus (PRRSV) isolates in Thailand (US and EU genotypes).

Authors:  Alongkorn Amonsin; Roongtham Kedkovid; Suphasawatt Puranaveja; Piya Wongyanin; Sanipa Suradhat; Roongroje Thanawongnuwech
Journal:  Virol J       Date:  2009-09-16       Impact factor: 4.099

10.  Actinobacillus pleuropneumoniae induces SJPL cell cycle arrest in G2/M-phase and inhibits porcine reproductive and respiratory syndrome virus replication.

Authors:  Jérémy A Ferreira Barbosa; Josée Labrie; Francis Beaudry; Carl A Gagnon; Mario Jacques
Journal:  Virol J       Date:  2015-11-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.